Please Note: This trial is no longer enrolling new participants
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Giredestrant plus Everolimus compared with Exemestane plus Everolimus in Patients with ER+, HER2-, Locally Advanced or Metastatic Breast Cancer
| Protocol No. | ML43171 | Scope | National |
|---|---|---|---|
| Principal Investigator | Bryan Schneider | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase III |
